News

Ontinue Celebrates Microsoft Security Excellence Award Finalist Spot

Ontinue Celebrates Microsoft Security Excellence Award Finalist Spot

Ontinue Honored as a Finalist for Microsoft Security Excellence Awards

Ontinue, a respected leader in agentic AI-powered managed extended detection and response (MXDR) services, proudly announces its status as a finalist in the 2025 Microsoft Security Excellence Awards, specifically within the distinguished Security Trailblazer category. This incredible acknowledgment highlights Ontinue's commitment to revolutionizing security solutions and enhancing outcomes for Microsoft Security customers around the globe.

The Significance of the Microsoft Security Excellence Awards

The Microsoft Security Excellence Awards celebrate exceptional innovation, operational excellence, and positive customer impact across various categories. The finalists represent the crème de la crème of the Microsoft Intelligent Security Association (MISA), a reliable ecosystem of cybersecurity partners that combine their solutions with Microsoft’s technology to reinforce protection for organizations everywhere. The Security Trailblazer distinction showcases partners who have demonstrated vital innovation and substantial customer success within the Microsoft security landscape.

Recognition of Advances in Security Operations

Geoff Haydon, the CEO of Ontinue, remarked on this recognition: "Being recognized as a Security Trailblazer finalist validates how effectively Ontinue collaborates with Microsoft to enhance security operations through agentic AI advancements. Our ION platform exemplifies this commitment, promoting faster outcomes, increased resilience, and greater value from Microsoft Security investments. We are shaping the future of SecOps, where AI not only accelerates efficiency but also broadens the realm of possibilities."

Innovations at Ontinue

Ontinue is known for its pioneering advancements, particularly through the ION MXDR platform, which enhances the capabilities of human experts with agentic AI and automation. This cutting-edge approach enables rapid threat containment and continuous enhancement of customer security. Earlier in the year, the introduction of the Autonomous Investigator agent resulted in a remarkable 55% reduction in response times to incidents, achieving a commendable 99.5% resolution rate for incidents.

Moreover, Ontinue unveiled its Posture Advisor agent in September, designed to audit Entra security policies and offer customized recommendations to enhance security against identity threats. This innovation is built on Microsoft Security Copilot, showcasing Ontinue's commitment to integrated security solutions.

Celebrating the Achievements of Cybersecurity Leaders

Maria Thomson, Director of the Microsoft Intelligent Security Association, expressed her congratulations to the finalists, stating, "These awards acknowledge the extraordinary accomplishments of MISA members in enhancing customer capabilities against security threats. We received numerous high-quality submissions this year, making the competition exceptionally fierce. This year’s finalists stand out amidst exceptional talent, and I am delighted to commend their efforts in the cybersecurity landscape."

Looking Forward: The Award Ceremony

Microsoft will honor the finalists, including Ontinue, at the Microsoft Security Excellence Awards ceremony on January 26, 2026. In total, six award categories will acknowledge partners recognized as innovators, trailblazers, and influential figures in the security domain. All finalists are committed members of the Microsoft Intelligent Security Association (MISA) and are dedicated to collaborating and adapting their solutions to tackle contemporary security challenges.

The MISA initiative unites leaders, software development organizations, and service partners aiming to safeguard against security threats and foster a safer world. Industry experts will join forces to vote for the award recipients, celebrating their significant contributions to collective security innovation.

About Ontinue

Ontinue stands at the forefront of cybersecurity as a leading provider of MXDR services, designed to empower modern organizations in feeling safe and confident while progressing through the digital age. Our mission focuses on reinventing managed security operations with Nonstop SecOps, which provides ongoing protection through trust, constant innovation, and support.

The ION platform's unique advantages stem from its integration of agentic AI and human expert insights while utilizing existing Microsoft tools to deliver unmatched security solutions. This results in rapid threat detection and resolution, continuous security elevation, and valuable time returned to CISOs and their teams to focus on strategic initiatives.

Moreover, the collaboration model of ION supports transparency and guarantees that security analysts can consistently access SecOps support and maintain full control of their data. With exceptional expertise in Microsoft products and frameworks, Ontinue aids CISOs and CIOs in maximizing their Microsoft security investments and consolidating their security toolsets efficiently.

Frequently Asked Questions

What is the Microsoft Security Excellence Awards?

The awards recognize partners in the cybersecurity field for their exceptional contributions to product innovation, customer impact, and operational excellence.

What role did Ontinue play in the awards?

Ontinue was awarded a finalist position in the Security Trailblazer category, reflecting its innovative approach to security operations.

How does Ontinue enhance security for organizations?

Ontinue's ION platform utilizes agentic AI and automation to improve threat detection and response times while strengthening overall security posture.

Who determines the winners of the awards?

The winners are selected by industry veterans within MISA and Microsoft, based on their contributions and effectiveness in enhancing security measures.

How can organizations benefit from Ontinue’s services?

Organizations can leverage Ontinue's managed security solutions to reduce incident response times, boost operational efficiency, and enhance their security framework using existing tools.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Cardinal Health Surges with Increased EPS Outlook

Updated Category News Views 111

Cardinal Health's Towering Numbers and Raised Outlook Holy moly, Cardinal Health is strutting out of the gate like they mean business. Their first quarter for fiscal year 2027 showed revenue hitting a hefty $67.5 billion—up 5% from last year. If you're holding NYSE:CAH, you might be grinning ear to ear right now. Cardinal didn’t just squeeze out more revenue; they saw...

Continue Reading
Verismo's SynKIR™-310 Shows Promise in Phase 1 Trials

Updated Category News Views 74

KIR-CAR: A Fresh Take on Cancer Treatment So, Verismo Therapeutics is at it again with their KIR-CAR platform. They're set to present interim data at this year's ASH Annual Meeting. To all those following B-cell non-Hodgkin Lymphoma (B-NHL) treatments, pay attention. SynKIR™-310, a CD19-targeted therapy, is showing some real promise. The science behind this is like...

Continue Reading
Mondego Bio Charges Ahead with Cancer Therapy Trials

Updated Category News Views 78

Cracking Cancer's Code: Mondego's Bold Move Big news from Portugal today—a quiet town called Cantanhede is now the epicenter of a potential game-changer in cancer therapy. Mondego Bio, with its small-molecule innovator MB?388, is diving headfirst into a Phase 1 clinical study. If you're scratching your head about the significance, let me spell it out: this is an attempt...

Continue Reading
Chris Auffenberg Delivers Ford Blue Advantage Gains

Updated Category News Views 18

Can't Ignore Ford's New Strategy in Pre-Owned Cars The auto industry may feel like a runaway train sometimes, and keeping up with the latest turns can be a headache. But here's something catching my eye: Chris Auffenberg Ford's new move with the Ford Blue Advantage certified pre-owned vehicles. It's not just any run-of-the-mill used car deal—this one's got some beef...

Continue Reading
Reviving Carbide Tools: Resharpening for Cost Control

Updated Category News Views 52

Trading Rust: Resharpening Carbide Cutting Tools Alright, picture this: you've got a toolbox full of worn carbide tools, each looking like they've seen better days. You might toss 'em out and grab some new ones, right? But hold on! Carl Ciesla, a cutting tool vet from Sanborn, NY, is talking all about how resharpening could be your ticket to saving a heap of cash and...

Continue Reading
Norwegian Cruise Line's Black Friday Big Splash

Updated Category News Views 65

Jump Aboard NCL's Black Friday Bargain Ship Grab your life jackets, folks! Norwegian Cruise Line (NCL) is sailing with an irresistible Black Friday offer: 50% off all cruises, complete with their much-lauded Free at Sea package. Yeah, if you've been fence-sitting about taking the plunge into the cruise lifestyle, now might just be the time to buckle up your life vests. A...

Continue Reading
Bioactive Research: Converting Science into Guidance

Updated Category News Views 0

Unlocking the Science of Dietary Bioactives Amidst a world swimming in kale smoothies and exotic teas, ILSI U.S. & Canada gathered the sharpest minds to discuss dietary bioactives, an area once shrugged off but now coming into its own. On October 28, 2026, over 250 folks from government, academia, and industry tuned in, looking to understand how these compounds, found in...

Continue Reading
Aker Solutions Lands Big Role in Qatar Oil Upgrade

Updated Category News Views 88

Qatari Venture Beckons Aker Solutions Well, it's not every day you hear about a decades-old oil field getting a facelift, and yet here we are. Aker Solutions has received a nod of approval with a letter of award from PTSC Mechanical and Construction Limited Company (PTSC M&C). This gig is all about the Maydan Mahzam oil field way off the Qatari coast—a legacy site...

Continue Reading
Utility Returns: Short-Term Savings, Long-Term Costs

Updated Category News Views 64

Crunching the Numbers on Utility Returns There's a buzz in the utility sector, and it's not just the hum of power lines—it’s all about return on equity (ROE). Concentric Energy Advisors just dropped some insights that could have us rethinking how these returns play into customer bills and utilities' financing capabilities. What's the Deal with ROE? Think of ROE like a...

Continue Reading
Qfin Faces Stock Lawsuit: Know Your Investor Rights

Updated Category News Views 82

Qfin in the Legal Hot Seat When you hear about a company's legal wranglings, especially one like Qfin Holdings, Inc., you've got to sit up and take notice. We're not talking about a quick scuffle here; this is a full-blown class action lawsuit with its talons sunk deep into allegations of securities law violations. They're squared off against DJS Law Group, an outfit that...

Continue Reading

Top 5 Most Recently Viewed Articles

M-DAQ Expands Footprint: Eyes Vietnam's Booming Economy

Updated Category News Views 51

Strategic Moves in the ASEAN Financial Arena Now, this one's got some bite to it. M-DAQ Global's foray into Vietnam isn't just another step on the fintech ladder - it's a bold expansion play into one of ASEAN's fastest up-and-comers. Forget the usual corporate fluff; what we're seeing here is a calculated strike to grab a piece of a pie that's only getting bigger. Why...

Continue Reading
IDEAYA Biosciences, Inc. Reports Strong Progress in 2024

Updated Category News Views 194

IDEAYA Biosciences, Inc. Achieves Significant Milestones in Financial Reporting IDEAYA Biosciences, Inc. (Nasdaq: IDYA), a pioneering precision medicine oncology company, recently shared its financial results for the fourth quarter and the full year of 2024. The company is dedicated to the discovery and development of targeted therapeutics, making noteworthy strides...

Continue Reading
5N Plus Inc. Enhances Supply Partnership with First Solar

Updated Category News Views 256

Introduction to the New Supply Agreement 5N Plus Inc. (TSX: VNP), a global leader in specialty semiconductors and performance materials, recently announced a major expansion of its supply agreement with First Solar, Inc. (NASDAQ: FSLR). This partnership is vital in supplying increased volumes of critical materials essential for the production of photovoltaic solar...

Continue Reading
Energy Services of America Shines at Upcoming Investor Conference

Updated Category News Views 162

Highlighting Energy Services of America's Upcoming Investor Conference Energy Services of America (NASDAQ: ESOA) is preparing to make a significant impact at an upcoming investor conference. The event will feature presentations by the company's top executives, providing insights into the organization’s future strategies and objectives. Key Presenters at the Conference...

Continue Reading
Ophthalmic Drugs Market Expected to Hit $67.83 Billion by 2033

Updated Category News Views 51

Overview of the Ophthalmic Drugs Market The ophthalmic drugs market is experiencing impressive growth, largely due to the increasing prevalence of eye diseases and innovative advancements in drug development. In 2023, the market was valued at USD 37.17 billion and is expected to grow at a remarkable CAGR of 6.2% from 2024 to 2033, surpassing USD 67.83 billion. Recent...

Continue Reading